Toll Free: 1-888-928-9744

Neurocrine Biosciences, Inc. - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 45 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Neurocrine Biosciences, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Neurocrine Biosciences, Inc. - Product Pipeline Review - 2014', provides an overview of the Neurocrine Biosciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Neurocrine Biosciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Neurocrine Biosciences, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Neurocrine Biosciences, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Neurocrine Biosciences, Inc.'s pipeline products

Reasons to buy

- Evaluate Neurocrine Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Neurocrine Biosciences, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Neurocrine Biosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Neurocrine Biosciences, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Neurocrine Biosciences, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Neurocrine Biosciences, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Neurocrine Biosciences, Inc. Snapshot 5
Neurocrine Biosciences, Inc. Overview 5
Key Information 5
Key Facts 5
Neurocrine Biosciences, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Neurocrine Biosciences, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Neurocrine Biosciences, Inc. - Pipeline Products Glance 13
Neurocrine Biosciences, Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Neurocrine Biosciences, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Neurocrine Biosciences, Inc. - Drug Profiles 15
NBI-69734 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
valbenazine 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
verucerfont 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Drug to Inhibit VMAT-2 for Schizophrenia and Movement Disorder 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
G Protein-Coupled Receptor 119 Agonist 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
GnRH Antagonists 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
GPCR Antagonist 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecules for CNS Disorders 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecules to Antagonize Melanocortin-4 Receptor for Cachexia 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Neurocrine Biosciences, Inc. - Pipeline Analysis 26
Neurocrine Biosciences, Inc. - Pipeline Products by Target 26
Neurocrine Biosciences, Inc. - Pipeline Products by Route of Administration 27
Neurocrine Biosciences, Inc. - Pipeline Products by Molecule Type 28
Neurocrine Biosciences, Inc. - Pipeline Products by Mechanism of Action 29
Neurocrine Biosciences, Inc. - Recent Pipeline Updates 31
Neurocrine Biosciences, Inc. - Dormant Projects 35
Neurocrine Biosciences, Inc. - Discontinued Pipeline Products 37
Discontinued Pipeline Product Profiles 37
tiplimotide 37
indiplon 37
prasterone 37
Neurocrine Biosciences, Inc. - Company Statement 38
Neurocrine Biosciences, Inc. - Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 45
Disclaimer 45
List of Tables
Neurocrine Biosciences, Inc., Key Information 5
Neurocrine Biosciences, Inc., Key Facts 5
Neurocrine Biosciences, Inc. - Pipeline by Indication, 2014 8
Neurocrine Biosciences, Inc. - Pipeline by Stage of Development, 2014 9
Neurocrine Biosciences, Inc. - Monotherapy Products in Pipeline, 2014 10
Neurocrine Biosciences, Inc. - Out-Licensed Products in Pipeline, 2014 11
Neurocrine Biosciences, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 12
Neurocrine Biosciences, Inc. - Phase II, 2014 13
Neurocrine Biosciences, Inc. - Preclinical, 2014 14
Neurocrine Biosciences, Inc. - Pipeline by Target, 2014 26
Neurocrine Biosciences, Inc. - Pipeline by Route of Administration, 2014 27
Neurocrine Biosciences, Inc. - Pipeline by Molecule Type, 2014 28
Neurocrine Biosciences, Inc. - Pipeline Products by Mechanism of Action, 2014 30
Neurocrine Biosciences, Inc. - Recent Pipeline Updates, 2014 31
Neurocrine Biosciences, Inc. - Dormant Developmental Projects,2014 35
Neurocrine Biosciences, Inc. - Discontinued Pipeline Products, 2014 37
Neurocrine Biosciences, Inc., Subsidiaries 43 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify